AI-generated summary
In a neonatal rat model of hypoxic-ischemic brain injury, the authors report that 7 days of 808 nm photobiomodulation reduced brain lesions in the cortex and hippocampal CA1 region. They associate the benefit with preserved mitochondrial function, less oxidative damage and fewer apoptotic neurons. The study was conducted in animals, and the abstract does not report a sample size.
- Who or what was studied
- Neonatal rats subjected to hypoxic-ischemic insult
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study is an animal model, and the abstract does not state a sample size or whether the findings apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Adenosine triphosphate, Light-emitting diode, Oxidative stress, Brain injury, Mitochondria, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.